Francis Agoada

Francis Agoada was a patient at Somerset Medical Center whose dangerously abnormal blood sugar after an insulin overdose became part of a wider pattern of unexplained incidents in the hospital’s Critical Care Unit. Her case linked an individual episode of suspected drug harm to an investigation that eventually involved six patients, while the available account leaves her personal outcome unstated.

Identity and Incident

The book provides few biographical details about Agoada beyond her status as a patient at Somerset Medical Center. In a retrospective list, her name appears as Frances Agoada; the hospital’s chronology identifies her as Ms. Francis Agoada. The account describes her blood sugar as having risen dangerously after Charles Cullen gave her an insulin overdose. It does not supply the date of the dose, the circumstances of its administration, or further clinical details about her condition.

Place in the Somerset Cases

Somerset’s senior vice president presented Agoada’s case among six patient incidents in the hospital’s Critical Care Unit. The chronology placed her on August 27, after the cases of Joseph Lehman, Frances Kane, Jin Kyung Han, and Reverend Florian Gall, and before McKinley Crews, whose death had occurred four days before the hospital notified the prosecutor’s office. The hospital described the cases as involving abnormal laboratory findings and life-threatening symptoms; five of the six patients had died. That figure applies to the group as a whole, however, and the account does not identify Agoada as one of the five deaths.

The medication evidence places her episode among the insulin cases in the cluster. When Somerset reported four incidents to the Department of Health, it identified Reverend Gall and Jin Kyung Han as digoxin cases and the others as insulin cases. A later account specifies the insulin overdose in Agoada’s case. Together, these details distinguish her episode from the digoxin poisonings without establishing how investigators proved the drug had been administered or who was responsible in her particular case.

Significance and Limits of the Record

Agoada’s case mattered in the investigation not as an isolated clinical anomaly but as one entry in a sequence of severe events that Somerset had been examining internally for months. The hospital’s six-case chronology made the recurrence visible, while the distinction between insulin and digoxin showed that the cluster involved more than one drug. Yet hospital officials did not identify a source for the incidents when they briefed investigators, and the account does not give Agoada’s subsequent medical course, whether she recovered, or whether her case led to a specific investigative finding.

The difference between what the record establishes and what it leaves unresolved is important. Agoada is identified as a patient whose blood sugar became dangerously abnormal after an insulin overdose, and her case is included in the hospital’s report of unexplained incidents. The supplied account does not provide a fuller personal history or a definitive individual outcome; her significance rests on the documented place of her episode within the larger Somerset pattern.